<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The down-regulation of miR-214 has previously been observed in human <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo> (<z:mp ids='MP_0003331'>HCC</z:mp>) </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we demonstrated the down-regulation of miR-214 is associated with cell invasion, stem-like traits and early recurrence of <z:mp ids='MP_0003331'>HCC</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Firstly, we validated the suppression of miR-214 in human <z:mp ids='MP_0003331'>HCC</z:mp> by real-time quantitative RT-PCR (qRT-PCR) in 20 paired <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and non-<z:e sem="disease" ids="C0023903" disease_type="Neoplastic Process" abbrv="">tumor liver</z:e> tissues of <z:mp ids='MP_0003331'>HCC</z:mp> patients and 10 histologically <z:mpath ids='MPATH_458'>normal</z:mpath> liver tissues from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Further qRT-PCR analysis of 50 <z:mp ids='MP_0003331'>HCC</z:mp> tissues from an independent cohort of <z:mp ids='MP_0003331'>HCC</z:mp> patients of whom 29 with early <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> (&lt;2 years) and 21 with late <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> demonstrated that the suppression of miR-214 was significantly more suppressed in samples from <z:mp ids='MP_0003331'>HCC</z:mp> patients with early <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> compared those from patients with no recurrence </plain></SENT>
<SENT sid="4" pm="."><plain>Re-expression of miR-214 significantly suppressed the growth of <z:mp ids='MP_0003331'>HCC</z:mp> cells in vitro and reduced their tumorigenicity in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>The enhancer of zeste homologue 2 (EZH2) and β-catenin (CTNNB1) was identified as two potential direct downstream targets of miR-214 through bioinformatics analysis and experimentally validated the miRNA-target interactions with a dual-firefly luciferase reporter assay </plain></SENT>
<SENT sid="6" pm="."><plain>In corroborate with this, both EZH2 and CTNNB1 are found to be significantly overexpressed in human <z:mp ids='MP_0003331'>HCC</z:mp> biopsies </plain></SENT>
<SENT sid="7" pm="."><plain>Since EZH2 can regulate CTNNB1, CTNNB1 can also be an indirect target of miR-214 through EZH2 </plain></SENT>
<SENT sid="8" pm="."><plain>Silencing EZH2 or CTNNB1 expression suppressed the growth and invasion of <z:mp ids='MP_0003331'>HCC</z:mp> cells and induced E-cadherin (CDH1), known to inhibit cell invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, the silencing of miR-214 or overexpression of EZH2 increased EpCAM(+) stem-like cells through the activation of CTNNB1 </plain></SENT>
<SENT sid="10" pm="."><plain>Interestingly, the up-regulation of EZH2, CTNNB1 and the down-regulation of CDH1 in <z:mp ids='MP_0003331'>HCC</z:mp> patients correlated with early <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e> and can be an independent predictor of poor survival </plain></SENT>
<SENT sid="11" pm="."><plain>Therefore, miR-214 can directly or indirectly target CTNNB1 to modulate the β-catenin signaling pathway in <z:mp ids='MP_0003331'>HCC</z:mp> </plain></SENT>
</text></document>